Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,106 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

NCT01527838

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Chronic Disease, +26 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program Boston, Massachusetts, United States
  • Ohio State Univeristy Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia

NCT01870596

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +25 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States
  • Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia

NCT00867672

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Klinikum der Technischen Universität Aachen Aachen, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
  • Augusta-Kranken-Anstalt gGmbH Bochum, Germany
  • Klinikum Braunschweig Braunschweig, Germany
View all 27 locations
View Trial Details
Completed

Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia

NCT01826214

Conditions
Acute Leukemias, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Duke University Medical Center SC-5 Durham, North Carolina, United States
  • Novartis Investigative Site Adelaide, South Australia, Australia
  • Novartis Investigative Site Prahran, Victoria, Australia
  • Novartis Investigative Site Salzburg, Austria
View all 23 locations
View Trial Details
Completed

Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML

NCT00123474

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Central Hematology Oncology Medical Group Inc. Alhambra, California, United States
  • Pacific Cancer Medical Center Inc Anaheim, California, United States
  • Loma Linda University Cancer Center Loma Linda, California, United States
View all 137 locations
View Trial Details
Completed

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

NCT00072475

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Ella Milbank Foshay Cancer Center at Jupiter Medical Center Jupiter, Florida, United States
View all 68 locations
View Trial Details

Related conditions